Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infection

JHEP Reports 2026 Open access

Read full text
Authors: Μargarita Papatheodoridi, Sofia Paraskevopoulou, Panagiota Ioannidou, Paraskevi Fytili, Dimitrios S. Karagiannakis, Alkistis Maria Papatheodoridi, Stratigoula Sakellariou, Εvangelos Cholongitas, Jiannis Vlachogiannakos, George Papatheodoridis
DOI: 10.1016/j.jhepr.2026.101771
Cited by: 0
References: 22

Abstract

BACKGROUND & AIMS: The optimal management and outcomes of patients with HBeAg-negative grey-zone (GZe-) chronic HBV infection remain debatable. We assessed the outcomes and real-life management of GZe-patients and compared them to patients with typical HBeAg-negative chronic infection (CIe-). METHODS: We included all HBeAg-negative patients with baseline HBV DNA ≤20,000 IU/ml or HBV DNA >20,000 IU/ml and ALT

Fields of Study & Subjects

Hepatitis B Virus Studies Hepatitis C virus research Liver Disease Diagnosis and Treatment

Publication details

Journal / source
JHEP Reports
Volume
8
Issue
4
Pages
101771–101771
Publication date
4 February 2026
Language
EN